Table 2.

Results of multivariable analyses estimating the odds of having symptoms lasting longer than 4 weeks and the odds of select duration of symptoms^a among participants with disabilities who reported testing positive for SARS-CoV-2 compared to participants without disabilities who tested SARS-CoV-2-positive^b.

	Odds Ratio (95% Confidence Interval)(ref: adults without disabilities)	P-value
Symptoms for >4 weeks
One or more symptom	1.65 (0.78, 3.50)	0.188
Two or more symptoms	1.91 (0.86, 4.21)	0.110
Myalgic encephalomyelitis/chronic fatigue syndrome-like (ME/CFS-like) symptomsc	2.60 (1.29, 5.24)	0.008
Digestive symptomsd	3.07 (1.36, 6.91)	0.007
Change in taste or smelle	1.68 (0.76, 0.37)	0.197
Upper respiratory symptomsf	1.95 (0.90, 4.24)	0.090
One or more symptoms by different duration
1–3 monthsa	1.31 (0.57, 3.02)	0.527
3–6 monthsa	3.38 (1.19, 9.59)	0.022
6–9 monthsa	0.58 (0.06, 5.33)	0.630
9–12 monthsa	2.00 (0.38, 10.57)	0.415

^aDuration of symptoms were mutually exclusive categories in the survey question but may overlap depending on how the respondent interpreted the survey question. For example, an individual who experienced three months of symptoms may have responded “1–3 months” or “3–6 months.”

^bStatistical weighting was used to align the sample with U.S. population distributions, adjusting for gender, age, household income, race/ethnicity, household size, education, census region, and metropolitan status. Weights were designed to match the U.S. Census' American Community Survey (ACS) proportions for these variables. Metropolitan status, which is not available from the 1-year ACS, were obtained from the Current Population Survey (CPS) March 2020 Annual Social and Economic Supplement (CPS-ASEC). Odds ratios were adjusted for age category, sex, race/ethnicity, highest level of education completed, employment status, and census region.

^cMyalgic encephalomyelitis/chronic fatigue syndrome-like (ME/CFS-like) symptoms include change in mood, “brain fog,” fatigue/tired/weakness, joint/muscle pain, palpitations (heart racing or pounding), post-exertional malaise, problems sleeping, and shortness of breath/breathlessness. (See Appendix B.)

^dDigestive symptoms include diarrhea, nausea/vomiting, and stomach pain. (See Appendix B.)

^eChange in taste or smell, a specific symptom for COVID infection1, was asked as one question, rather than as two separate symptoms, as on other surveys of patients with PCC. (See Appendix B.)

^fUpper respiratory symptoms include cough and sore throat. (See Appendix B.)